Anzeige
Mehr »
Samstag, 07.06.2025 - Börsentäglich über 12.000 News
5-Dollar-Kupfer. KI-Infrastruktur. Energiewende. Vizsla Copper hat die Pfunde im Boden, die jetzt zählen.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1WZEV | ISIN: SE0003943620 | Ticker-Symbol: EN9
Frankfurt
06.06.25 | 08:01
0,236 Euro
-3,67 % -0,009
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
ENZYMATICA AB Chart 1 Jahr
5-Tage-Chart
ENZYMATICA AB 5-Tage-Chart

Aktuelle News zur ENZYMATICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
ENZYMATICA Aktie jetzt für 0€ handeln
07.05.Bulletin from the annual general meeting of Enzymatica AB (publ) on May 7, 2025 1
05.05.ENZYMATICA AB: Enzymatica gears up for global expansion after a strong first quarter3
29.04.Enzymatica AB: Quarterly report Q1/2025: Enzymatica strengthens its position in home markets and focuses on international expansion205LUND, Sweden, April 29, 2025 /PRNewswire/ -- First quarter Net sales amounted to SEK 12.3 million (9.4).Operating result amounted to SEK -18.0 million (-18.4).Earnings per share...
► Artikel lesen
02.04.Notice of Annual General Meeting 2025 in Enzymatica AB (publ)3
11.03.ENZYMATICA AB: Enzymatica's results published in The Journal of Physiology3
06.03.ENZYMATICA AB: Replay Link to Digital Press Briefing - March 5, 20253
28.02.Enzymatica AB: Invitation to Press Briefing - 5 March 2025308STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- In connection with the publication of results from two independent research studies on ColdZyme, Enzymatica AB invites to a digital press briefing...
► Artikel lesen
28.02.Enzymatica AB: New independent studies show that ColdZyme addresses the root cause of respiratory infections, reducing sick days and symptoms344STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- Today, results from two independent studies on the medical device ColdZyme were published in the peer-reviewed scientific journal The Journal of Physiology....
► Artikel lesen
25.02.ENZYMATICA AB: Enzymatica boosts Q4 revenue but sees room for stronger partner sales6
18.02.Enzymatica AB: Year-end report 2024: Strong performance in core markets - preparing for international growth225LUND, Sweden, Feb. 18, 2025 /PRNewswire/ -- Fourth quarter January-December • Net sales reached SEK 17.2 million (15.8). • The operating result totaled SEK -13.7...
► Artikel lesen
14.01.ENZYMATICA AB: Enzymatica recruits experienced marketing director1
09.01.ENZYMATICA AB: Enzymatica focuses on growth with new recruitment - Anna Söderlund joins as Senior Director Marketing & Sales1
07.11.24Enzymatica AB's Interim report Q3/2024: Focus on developing existing and new markets354LUND, Sweden, Nov. 7, 2024 /PRNewswire/ -- Third quarter January-September Net sales reached SEK 12.6 (13.3) million. The operating result totaled...
► Artikel lesen
22.08.24XFRA CAPITAL ADJUSTMENT INFORMATION - 22.08.2024487Das Instrument EBZ BMG2109G1033 CHINA GAS HLDGS HD-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 22.08.2024 und ex Kapitalmassnahme am 23.08.2024 The instrument EBZ BMG2109G1033 CHINA GAS HLDGS...
► Artikel lesen
06.08.24Bulletin from the extraordinary general meeting of Enzymatica AB (publ) on 6 August 2024371The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. LUND, Sweden, Aug. 6...
► Artikel lesen
18.07.24Enzymatica AB: Interim report Q2/2024: Enzymatica builds momentum for expansion552LUND, Sweden, July 18, 2024 /PRNewswire/ -- Second quarter January-June Net sales reached SEK 6.4 (8.8) million. The operating...
► Artikel lesen
18.07.24Enzymatica AB: Enzymatica's Board of Directors updates the financial targets719LUND, Sweden, July 18, 2024 /PRNewswire/ -- The Board of Directors of Enzymatica AB (publ) has decided to update the company's financial goals. The background is that the company will likely...
► Artikel lesen
18.07.24Notice of Extraordinary General Meeting in Enzymatica AB (publ)559LUND, Sweden, July 18, 2024 /PRNewswire/ -- The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the "Company") are hereby invited to attend the Extraordinary General Meeting ("EGM")...
► Artikel lesen
18.07.24Enzymatica AB: Enzymatica's Board of Directors decides on a new rights issue of approximately SEK 130 million151NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, BELARUS, SINGAPORE...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1